These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1827182)

  • 1. [Convulsive seizures under viloxazine therapy].
    Langs T; Thomas F; Jupas JJ; Ravaud Y
    Presse Med; 1991 Mar; 20(10):477. PubMed ID: 1827182
    [No Abstract]   [Full Text] [Related]  

  • 2. Does viloxazine have epileptogenic properties?
    Edwards JG; Glen-Bott M
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):960-4. PubMed ID: 6434699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convulsive seizures and viloxazine.
    Edwards JG
    Br Med J; 1977 Jul; 2(6079):96-7. PubMed ID: 871809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 5. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
    Magnus RV
    J Int Med Res; 1975; 3(3):207-13. PubMed ID: 162677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 8. Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects.
    Edwards JG
    Curr Med Res Opin; 1977; 5(3):226-33. PubMed ID: 162658
    [No Abstract]   [Full Text] [Related]  

  • 9. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
    Sedman G
    Curr Med Res Opin; 1977; 5(3):217-25. PubMed ID: 162657
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
    León CA; Vigoya J; Conde S; Campo G; Castrillón E; León A
    Acta Psiquiatr Psicol Am Lat; 1994 Mar; 40(1):41-9. PubMed ID: 8053353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation with viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Lille Med; 1979 Dec; 24(10):821-4. PubMed ID: 529970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute poisoning by viloxazine chlorhydrate taken by itself].
    Falcy M; Riboulet-Delmas G; Efthymiou ML
    Encephale; 1983; 9(2):137-44. PubMed ID: 6641615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.